As coronavirus continues to alter our way of life, it also impacts the IP landscape. Staying up-to-date on the latest deadlines, court changes and overall business climate while managing your IP risks can feel overwhelming. The Wolf Greenfield team is here to help. This resource center includes:
Amgen and the Amgen Foundation have committed up to $12.5 million to support COVID-19 relief efforts.
The Analog Devices Foundation donated $500,000 to Massachusetts General Hospital’s Vaccine & Immunotherapy Center to advance COVID-19 vaccine development.
BioAegis is developing rhu-pGSN (recombinant human plasma gelsolin) based on a patent portfolio licensed from The Brigham and Women’s Hospital.
Boehringer Ingelheim donated $1 million in goods to the China Red Cross Foundation and is investigating antiviral compounds from past research against SARS-CoV2.
Grocery delivery startup Boxed sees soaring demand amid pandemic. The company is prioritizing first responders’ orders.
The Broad Institute is contributing to Massachusetts’s COVID-19 diagnostic testing, developing new diagnostic technologies and data analysis tools, and generating new biological insights.
Butterfly Network’s portable ultrasound can image lungs or hearts hurt from coronavirus and hopes to lessen the stress on the health care system.
Comrad has donated over $30,000 worth of compression socks to nurses and doctors at the front line and they are accepting donations to provide more.
Dana-Farber Cancer Institute began running low on critical PPE and researchers found a solution.
Dean Kamen of DEKA helped secure a shipment of protective equipment from China for New Hampshire.
FLIR Systems was quoted in an article about how thermal imaging cameras are the latest devices businesses hope will help reopen the economy.
Formlabs, University of South Florida Health, Northwell Health and Tampa General Hospital joined forces to create 3D printed nasal swabs to test for COVID-19 in patients in emergency shortage situations.
In addition, the FDA granted Formlabs emergency clearance for 3D-printed ventilator component.
GreenLight Biosciences is expanding their vaccine efforts to establish a scalable current Good Manufacturing Practices (cGMP) manufacturing platform to allow for the production of almost any RNA-based COVID-19 vaccine at a scale and cost that enables global delivery. In addition, they are advancing a number of RNA-based vaccines and therapeutics against COVID-19.
Judy, an in-case-of-emergency kit startup that is promising to be “ready for anything,” is working with experts to create curated disaster boxes based on where people live.
Eli Lilly and Co. reached an agreement with the National Institutes of Health to study one of its drugs as a COVID-19 treatment. The drug is approved in more than 65 countries as a treatment for adults with moderately to severely active rheumatoid arthritis.
They also opened labs and planned drive-thrus to help boost Indiana's COVID-19 testing capacity.
Kaleido Biosciences has initiated a controlled clinical study of Microbiome Metabolic Therapy KB109 in outpatients with mild-to-moderate COVID-19.
Since then, Kaleido Biosciences has initiated a controlled clinical study with Mass General Hospital of Microbiome Metabolic Therapy KB109 in outpatients with mild-to-moderate COVID-19.
A group at MIT figured out how to make an emergency ventilator for $100 using a common hospital item—instead of the usual $30,000.
After starting human trials for a COVID-19 vaccine, Moderna was featured on 60 minutes.
Since then, their potential coronavirus vaccine got $483 million boost from Feds.
Moderna announced positive interim Phase 1 data for its mRNA vaccine (mRNA-1273) against novel coronavirus.
Moderna, the first company to start US clinical trials of a Covid-19 vaccine, finished enrolling all 30,000 of its participants.
Early data shows Moderna's coronavirus vaccine is 94.5% effective.
Moderna intends to apply to the US Food and Drug Administration for authorization of its Covid-19 vaccine.
NOBULL is donating thousands of CDC recommended face masks to medical professionals. They were able to access the masks from an FDA registered factory through their partners. They are accepting donations to procure face masks or other PPE for medical professionals.
Nuance Communications announced the Nuance Dragon Ambient eXperience solution for telehealth providers.
BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), will accept an Indefinite Delivery Indefinite Quantity (IDIQ) contract award to provide Commercial Surge Capacity Testing for COVID-19 Emergency Response to the Centers for Disease Control and Prevention (CDC).
Pluristem Therapeutics Inc. (PSTI) announced it has treated its first patient suffering from COVID-19 under the FDA Single Patient Expanded Access Program.
Pfizer and BioNTech are co-developing a potential COVID-19 vaccine.
Pfizer and the Pfizer Foundation have also announced the commitment of $40 million in medical and charitable cash grants to help combat the global health effects of the COVID-19 pandemic in the US and around the world.
Researchers across the globe are deploying Quanterix Corporation’s Simoa® technology to profile innate immune response in COVID-19 patients, with the aim of identifying indicators associated with poor outcomes and opening new avenues for targeted therapies.
Translate Bio and Sanofi Pasteur are collaborating to develop a novel mRNA vaccine candidate against COVID-19.
The sweeping impacts of COVID-19 are immeasurable and, at times, defeating. We have taken solace in the fact that people across the globe are coming together (while remaining socially distant) to help address and overcome this pandemic. As a firm, we feel incredibly fortunate to support clients across industries and geographies–some of whom were part of the earliest adopters in shifting gears and focusing on efforts to combat coronavirus.
During this unprecedented time, we want you to know that we are still here to help. We vow to provide you with the high level of service you deserve, and we will do everything we can to have a positive impact on you. We want our clients to be able to focus on their families and know their IP interests are safe with us.
Our sincere thoughts are with those impacted by the virus.
Mechanical Technologies Chair
Electrical Computer Technologies Chair
Chemical & Material Technologies Chair
Trademark & Copyright Chair
Wolf, Greenfield & Sacks, P.C.,© 2021 Wolf, Greenfield & Sacks, P.C. All Rights Reserved.
600 Atlantic Avenue, Boston, MA 02210, +1 617-646-8000
605 Third Avenue, New York, NY 10158, +1 212-697-7890